SLAMF7 (Human) Recombinant Protein
* The price is valid only in USA. Please select country.
-
More Files
- More Functions
Result of bioactivity analysis
Result of bioactivity analysis
-
Specification
Product Description
Human SLAMF7 (Q9NQ25, 23 a.a. - 226 a.a.) partial recombinant protein with His-Avi tag at C-terminus expressed in Expi293 cells.
Sequence
SGPVKELVGSVGGAVTFPLKSKVKQVDSIVWTFNTTPLVTIQPEGGTIIVTQNRNRERVDFPDGGYSLKLSKLKKNDSGIYYVGIYSSSLQQPSTQEYVLHVYEHLSKPKVTMGLQSNKNGTCVTNLTCCMEHGEEDVIYTWKALGQAANESHNGSILPISWRWGESDMTFICVARNPVSRNFSSPILARKLCEGAADDPDSSM
Host
Mammals
Theoretical MW (kDa)
40-50
Form
Lyophilized
Preparation Method
Mammalian cell (Expi293) expression system
Purity
> 95% by SDS-PAGE
Endotoxin Level
< 1 EU per 1 ug of protein (determined by LAL method)
Activity
Immobilized SLAMF7, His & Avi Tag at 1.0 ug/mL (100 uL/Well). Dose response curve for Elotuzumab with the EC50 of 42.6 ng/mL determined by ELISA.
Quality Control Testing
SDS-PAGE under reducing condition
Storage Buffer
Lyophilized from sterile distilled Water up to 100 ug/mL
Storage Instruction
Store at -80°C.
Aliquot to avoid repeated freezing and thawing.Note
Result of bioactivity analysis
-
Applications
Functional Study
SDS-PAGE
-
Gene Info — SLAMF7
Entrez GeneID
57823Protein Accession#
Q9NQ25Gene Name
SLAMF7
Gene Alias
19A, CD319, CRACC, CS1
Gene Description
SLAM family member 7
Omim ID
606625Gene Ontology
HyperlinkOther Designations
19A24 protein|CD2-like receptor activating cytotoxic cells|OTTHUMP00000025677|novel LY9 (lymphocyte antigen 9) like protein
-
Interactome
-
Disease
- +1-909-264-1399
+1-909-992-0619
Toll Free : +1-877-853-6098 - +1-909-992-3401
- sales@abnova.com